Transforming brain tumor biology into hearing-preserving therapies
The David Lab
In the David Lab, we're redefining how we understand and treat tumors that cause hearing loss. We are also uncovering the molecular and RNA-level programs that drive tumor growth and neural dysfunction, leveraging advanced single-cell and long-read technologies alongside human model systems. Our mission is to transform these insights into targeted therapies that preserve hearing and improve quality of life.
Supported by the Lou and Jean Malnati Brain Tumor Institute of the Robert H. Lurie Comprehensive Cancer Center
